Bench to Bedside Pt. 2: Financial Toxicity in Patients With Hematologic Malignancies
In the second episode of this Hematopoiesis Bench to Bedside series, Dr. Manuel Espinoza-Gutarra has conversations with Dr. Aaron Mitchell, Dr. Yousuf Zafar (@yzafar), Dr. Aju Mathew, and Dr. Nandita Khera (@khera_nandita), experts in the field of financial toxicity in cancer patients, who offer different perspectives regarding the impact of the financial costs of modern anticancer treatment puts on patients, how should we adequately measure it and how to tackle it.Music: “Somebody New” RYYZN (www.toneden.io/ryyzn/post/somebody-new-copyright-free). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Hematopoiesis: An ASH Trainee Council Production
Ask The Program Directors: Do’s and Don'ts of Applying to Hematology Fellowship
Choosing Your Ideal Mentor
Celebrating Pride Month with Career Development Advice for LGBTQ+ Hematology Trainees
Caring for Older Adults with Blood Disorders: An Introduction to Geriatric Hematology
Get summaries like this every morning.
Free AI-powered recaps of Hematopoiesis: An ASH Trainee Council Production and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.